팬젠 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 휴온스, was filed 20 Mar 2026.
팬젠: what insiders have been doing
팬젠, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). From 31 October 2025 to 31 October 2026, the disclosure feed for 팬젠 logged 9 filings by 4 insiders.
Both sides are active: 2 purchases worth €3.1M and 4 sales, from 1 insider and 4 insiders respectively. The totals do not cover 5 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €3.1M, the purchase published on 20 March 2026 by 휴온스 is the largest of the period (7.4% of market cap).
The clock since the last published purchase (20 March 2026) now reads 235 days. Typically, a trade is published a median of 4 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 9 filings, this issuer sits above that mark. Since 2021, the database holds 15 purchases and 14 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -12.4%Entry 4,890.00 · Close 30 Oct 2026 4,285.00
- +8.3%Entry 6,240.00 · Close at T+365 6,760.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 5,600 sharesShareKRXDART:20260424000554
- 817,534 shares@ ₩6,474.007.38% mcap100.0% of flowShareKRXDART:20260320000900Canonical exit: 14 Jun 2026 (T+90)
- 817,534 sharesKRXDART:20260320000891Canonical exit: 14 Jun 2026 (T+90)
- 831,203 sharesKRXDART:20260318001148
- 142,436 sharesShareKRXDART:20260309001772
- 1,089 sharesKRXDART:20260309001753
- ShareKRXDART:20260213002659
- ShareKRXDART:20260213002623
- ShareKRXDART:20260127000296
- 11,147 sharesShareKRXDART:20250702000462
- 368,527 sharesShareKRXDART:20250428000155
- 142,436 sharesShareKRXDART:20241219000109Canonical exit: 19 Mar 2025 (T+90)
- 400,000 sharesKRXDART:20241219000111Canonical exit: 13 Mar 2025 (T+90)
- 1,534,878 sharesShareKRXDART:20241219000110Canonical exit: 19 Mar 2025 (T+90)
- 1,534,878 sharesShareKRXDART:20241218000350
- 1,534,878 sharesKRXDART:20241217000358
- 1,112,500 sharesShareKRXDART:20241120000065Canonical exit: 18 Feb 2025 (T+90)
- 1,163,134 sharesKRXDART:20241120000064Canonical exit: 12 Feb 2025 (T+90)
- 400,000 sharesKRXDART:20241114000390
- 1,534,878 sharesKRXDART:20241112000443Canonical exit: 3 Feb 2025 (T+90)
- 0KRXDART:20241111000383
- ShareKRXDART:20230821000398
- 0KRXDART:20230821000432
- ShareKRXDART:20230710000430
- 0KRXDART:20230328000802
25 of 60 declarations
About 팬젠
팬젠 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of biopharmaceutical solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
